FDA Approved: MYQORZO — Original Application (Cytokinetics Inc.)

View source ↗

Summary

The FDA approved MYQORZO (aficamten) from Cytokinetics as an original-application approval for the treatment of symptomatic obstructive hypertrophic cardiomyopa…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertrophic Cardiomyopathy

Drugs mentioned

• MYQORZO (aficamten)

Snippet

ORIG AP for MYQORZO (AFICAMTEN)